Prism Medico and Pharmacy Limited
BSE: PRISMMEDI
Prev Close
14.11
Open Price
14.59
Volume
3,297
Today Low / High
13.7 / 14.59
52 WK Low / High
11.62 / 25.79
Range
13 - 15
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 13.84, reflecting a change of -0.27 (-1.91354%). The expected target range on the BSE is 13 - 15. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Prism Medico and Pharmacy Limited Graph
Prism Medico and Pharmacy Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Prism Medico and Pharmacy Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 13.84, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 13.84 | 13.98 | 12.58 - 15.38 |
| 14.12 | 11.29 - 16.94 | ||
| 14.26 | 9.98 - 18.53 | ||
| Bearish Scenario | 13.84 | 13.70 | 12.33 - 15.07 |
| 13.56 | 10.85 - 16.28 | ||
| 13.42 | 9.40 - 17.45 |
Overview of Prism Medico and Pharmacy Limited
ISIN
INE730E01016
Industry
Financial - Conglomerates
Vol.Avg
6,897
Market Cap
83,917,871
Last Dividend
0
Official Website
IPO Date
2004-08-20
DCF Diff
13.61
DCF
1
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.63 Cr | 0.45 Cr | 0.18 Cr | 0.2902 | 0.00 Cr | 0.00 Cr | -0.08 Cr | -0.05 Cr | -0.08 | -0.06 Cr | -0.0771 |
| 2024-03-31 | 2.93 Cr | 2.56 Cr | 0.36 Cr | 0.1246 | 0.00 Cr | 0.45 Cr | -0.09 Cr | -0.02 Cr | -0.04 | -0.08 Cr | -0.0073 |
| 2023-03-31 | 1.27 Cr | 1.14 Cr | 0.13 Cr | 0.1022 | 0.00 Cr | 0.10 Cr | -0.10 Cr | -0.08 Cr | -0.13 | -0.10 Cr | -0.0601 |
| 2022-03-31 | 8.44 Cr | 8.63 Cr | -0.18 Cr | -0.0218 | 0.00 Cr | 0.02 Cr | -0.50 Cr | -0.37 Cr | -0.61 | -0.49 Cr | -0.0438 |
| 2021-03-31 | 16.76 Cr | 16.67 Cr | 0.10 Cr | 0.0057 | 0.00 Cr | 0.07 Cr | -0.17 Cr | -0.13 Cr | -0.21 | -0.16 Cr | -0.0078 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.07 Cr | 15.56 Cr | 0.47 Cr | 15.0928 Cr | 0.00 Cr | -0.07 Cr | 6.77 Cr | 0.03 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.4716 Cr |
| 2024-03-31 | 0.08 Cr | 15.24 Cr | 0.10 Cr | 15.1415 Cr | 0.00 Cr | -0.08 Cr | 6.77 Cr | 0.03 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.1015 Cr |
| 2023-03-31 | 0.10 Cr | 15.39 Cr | 0.23 Cr | 15.1615 Cr | 0.00 Cr | -0.10 Cr | 6.77 Cr | 0.03 Cr | 0.03 Cr | 0.00 Cr | 0.00 Cr | 0.2317 Cr |
| 2022-03-31 | 0.06 Cr | 12.57 Cr | 0.02 Cr | 12.5548 Cr | 0.00 Cr | -0.06 Cr | 6.77 Cr | 0.05 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0174 Cr |
| 2021-03-31 | 0.08 Cr | 21.54 Cr | 8.62 Cr | 12.9259 Cr | 0.00 Cr | -0.08 Cr | 4.85 Cr | 0.06 Cr | 0.00 Cr | 0.00 Cr | 1.94 Cr | 8.6161 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.0165 Cr | 0.0000 Cr | -0.0017 Cr | -0.0165 Cr | -0.0182 Cr | 0.0654 Cr | 0.0000 Cr | -0.0487 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr |
| 2024-03-31 | -0.0050 Cr | 0.0000 Cr | -0.0071 Cr | -0.0050 Cr | -0.0121 Cr | 0.0836 Cr | 0.0000 Cr | -0.0280 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr |
| 2023-03-31 | 2.9543 Cr | -2.9133 Cr | -0.0003 Cr | 2.9543 Cr | 0.0406 Cr | 0.0957 Cr | 0.0000 Cr | -0.1022 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr |
| 2022-03-31 | -2.3790 Cr | 2.3504 Cr | -0.0005 Cr | -2.3790 Cr | -0.0290 Cr | 0.0551 Cr | 0.0000 Cr | -0.4989 Cr | 0.0000 Cr | 0.0000 Cr | -1.9240 Cr |
| 2021-03-31 | -0.0515 Cr | 0.0241 Cr | -0.0002 Cr | -0.0515 Cr | -0.0276 Cr | 0.0841 Cr | 0.0000 Cr | -0.1752 Cr | 0.0000 Cr | 0.0000 Cr | -4.7991 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.07 Cr | 0.01 Cr | 0.06 Cr | 0.8420 | 0.01 Cr | 0.04 Cr | 0.07 | 0.02 Cr | 0.5701 |
| 2024-12-31 | 0.21 Cr | 0.15 Cr | 0.06 Cr | 0.2704 | -0.01 Cr | -0.01 Cr | -0.02 | -0.01 Cr | -0.0460 |
| 2024-09-30 | 0.29 Cr | 0.24 Cr | 0.05 Cr | 0.1772 | 0.01 Cr | 0.01 Cr | 0.02 | 0.01 Cr | 0.0327 |
| 2024-06-30 | 0.06 Cr | 0.06 Cr | 0.00 Cr | 0.0542 | -0.09 Cr | -0.09 Cr | -0.15 | -0.09 Cr | -1.4354 |
| 2024-03-31 | 0.15 Cr | 0.11 Cr | 0.03 Cr | 0.2134 | -0.17 Cr | -0.07 Cr | -0.11 | -0.14 Cr | -0.4666 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.07 Cr | 0.00 Cr | 0.07 Cr | 7.10 Cr | 6.77 Cr | 15.30 Cr | 0.03 Cr | 15.56 Cr | 0.47 Cr |
| 2024-09-30 | 0.08 Cr | 0.00 Cr | 0.08 Cr | 7.33 Cr | 6.77 Cr | 14.91 Cr | 0.03 Cr | 15.16 Cr | 0.10 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.08 Cr | 0.00 Cr | 0.00 Cr | 0.08 Cr | 0.00 Cr | 0.00 Cr | -15.14 Cr |
| 2024-03-31 | 0.08 Cr | 0.00 Cr | 0.08 Cr | 3.69 Cr | 6.77 Cr | 14.99 Cr | 0.03 Cr | 15.24 Cr | 0.10 Cr |
| 2023-12-31 | -0.08 Cr | 0.16 Cr | 0.08 Cr | 0.00 Cr | 0.00 Cr | 0.08 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -0.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -0.07 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 0.19 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | -0.05 Cr | 0.47 Cr | -0.48 Cr | 0.00 Cr | -0.05 Cr | -0.05 Cr | 0.00 Cr | 0.00 Cr | 0.47 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Financial - Conglomerates
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Bajaj Finserv Ltd. | BAJAJFINSV | ₹1,914.40 | ₹3,057,593,112,746.00 | ₹710,011.00 |
| Aditya Birla Capital Limited | ABCAPITAL | ₹269.70 | ₹704,192,094,000.00 | ₹3,151,774.00 |
| India Grid Trust | INDIGRID-IV | ₹158.09 | ₹131,935,274,220.00 | ₹309,156.00 |
Key Executives
Gender: female
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
FAQs about Prism Medico and Pharmacy Limited
The CEO is Sakshi Laller.
The current price is ₹13.84.
The range is ₹11.62-25.79.
The market capitalization is ₹8.39 crores.
The P/E ratio is -172.32.
The company operates in the Financial Services sector.
Overview of Prism Medico and Pharmacy Limited (ISIN: INE730E01016) is a leading Financial - Conglomerates in India. With a market capitalization of ₹8.39 crores and an average daily volume of 6,897 shares, it operates in the Financial - Conglomerates. The company last declared a dividend of ₹0.